Maria Ada Eufemia Forss
Chief Executive Officer chez BICO GROUP AB
Fortune : 24 494 $ au 31/03/2024
Profil
Maria Ada Eufemia Forss is currently the President & Chief Executive Officer at BICO Group AB since 2023.
She is also an Independent Director at LIDDS AB and a Director at Mabtech AB.
Previously, she held the position of Chief Executive Officer at DuoCort Pharma AB.
She also served as the Chairman of Bico International AB and Deputy Director at Laccure AB.
Additionally, she was a Director at Oncorena AB and Oncorena Holding AB.
From 2012 to 2023, she worked at Vitrolife AB as the VP-Business Development & Global Communications.
She was also the Head-Business Development at Aqilion AB and a Principal at AstraZeneca A.
Ms. Forss completed her undergraduate and MBA degrees from Concordia University.
She also holds a graduate degree from Handelshögskolan i Göteborg.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
VITROLIFE AB
0,00% | 31/12/2022 | 1 303 ( 0,00% ) | 24 494 $ | 31/03/2024 |
Postes actifs de Maria Ada Eufemia Forss
| Sociétés | Poste | Début |
|---|---|---|
| LIDDS AB | Director/Board Member | 01/01/2015 |
| BICO GROUP AB | Chief Executive Officer | 20/11/2023 |
Mabtech AB
 Mabtech AB Miscellaneous Commercial ServicesCommercial Services Mabtech AB manufactures immunological and biotechnological products. It produces a wide range of monoclonal antibodies to cytokines, immunoglobulins, and apolipoproteins for applications in life science research. The firm's products Elisa, Elispot, and Fluorospot Kits; antibodies; and supplementary products. The company was founded by Staffan Paulie, Kjell Olov Östrand, and Sten Braesch-Andersen in 1986 and is headquartered in Nacka Strand, Sweden. | Director/Board Member | - |
Anciens postes connus de Maria Ada Eufemia Forss
| Sociétés | Poste | Fin |
|---|---|---|
| VITROLIFE AB | Public Communications Contact | - |
| Bico International AB | Chairman | - |
Oncorena AB
 Oncorena AB Pharmaceuticals: MajorHealth Technology Oncorena AB develops a novel pharmacological treatment for metastatic renal clear cell cancer. It conducts clinical trial for potential new therapies in humans. The company was founded in 2011 and is headquartered in Helsingborg, Sweden. | Director/Board Member | - |
Aqilion AB
 Aqilion AB Investment ManagersFinance Aqilion AB is a venture capital firm. The firm was founded in 2002 by Jan Ekberg and Mats G. Ringesten. It's headquartered in Helsingborg, Sweden. | Corporate Officer/Principal | - |
DuoCort Pharma AB
 DuoCort Pharma AB Pharmaceuticals: MajorHealth Technology DuoCort Pharma AB conducts research, development, training, marketing, and sales in the medical field. The firm operates drug development company focused on improving glucocorticoid therapy. It develops Plenadren, a once daily dual-release hydrocortisone replacement therapy for patients with chronic adrenal insufficiency. The company was founded on July 6, 2007 and is headquartered in Stockholm, Sweden. | Chief Executive Officer | - |
Formation de Maria Ada Eufemia Forss
| Concordia University | Masters Business Admin |
| Handelshögskolan i Göteborg | Graduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| VITROLIFE AB | Health Technology |
| LIDDS AB | Health Technology |
| BICO GROUP AB | Health Technology |
| Entreprise privées | 8 |
|---|---|
Aqilion AB
Aqilion AB Investment ManagersFinance Aqilion AB is a venture capital firm. The firm was founded in 2002 by Jan Ekberg and Mats G. Ringesten. It's headquartered in Helsingborg, Sweden. | Finance |
AstraZeneca A/S /Denmark/
 AstraZeneca A/S /Denmark/ Pharmaceuticals: MajorHealth Technology AstraZeneca A/S sells and distributes pharmaceutical products to the health sector. It specializes within therapy areas of the gastrointestinal diseases, respiratory diseases, cardiovascular diseases, neuroscience, and oncology. The company was founded in 1943 and is headquartered in Copenhagen, Denmark. | Health Technology |
Laccure AB
 Laccure AB Pharmaceuticals: GenericHealth Technology Laccure AB develops products for the treatment and prevention of bacterial vaginosis. It is a pharmaceutical company that offers non-prescription vaginal tablet for women. The firm's product is based on a proprietary substance that releases lactic acid over an extended period of time to decrease elevated vaginal potential of hydrogen. It engages in research, development, training, marketing, and sales in the field of skin care and hygiene activities. The company was founded by Olov Arvid Sterner in 2007 and is headquartered in Helsingborg, Sweden. | Health Technology |
DuoCort Pharma AB
DuoCort Pharma AB Pharmaceuticals: MajorHealth Technology DuoCort Pharma AB conducts research, development, training, marketing, and sales in the medical field. The firm operates drug development company focused on improving glucocorticoid therapy. It develops Plenadren, a once daily dual-release hydrocortisone replacement therapy for patients with chronic adrenal insufficiency. The company was founded on July 6, 2007 and is headquartered in Stockholm, Sweden. | Health Technology |
Oncorena AB
Oncorena AB Pharmaceuticals: MajorHealth Technology Oncorena AB develops a novel pharmacological treatment for metastatic renal clear cell cancer. It conducts clinical trial for potential new therapies in humans. The company was founded in 2011 and is headquartered in Helsingborg, Sweden. | Health Technology |
Mabtech AB
Mabtech AB Miscellaneous Commercial ServicesCommercial Services Mabtech AB manufactures immunological and biotechnological products. It produces a wide range of monoclonal antibodies to cytokines, immunoglobulins, and apolipoproteins for applications in life science research. The firm's products Elisa, Elispot, and Fluorospot Kits; antibodies; and supplementary products. The company was founded by Staffan Paulie, Kjell Olov Östrand, and Sten Braesch-Andersen in 1986 and is headquartered in Nacka Strand, Sweden. | Commercial Services |
Oncorena Holding AB
 Oncorena Holding AB Pharmaceuticals: MajorHealth Technology Oncorena Holding AB develops novel pharmacological treatment for metastatic renal clear cell cancer. It conducts clinical trial for potential new therapies. The company was founded by Björn Oskar Larsson in 2011 and is headquartered in Helsingborg, Sweden. | Health Technology |
| Bico International AB |
